Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 256

Showing 1-25 of 256 citing articles:

Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)
Cornelius Engelmann, Adam Herber, Annegret Franke, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1346-1354
Open Access | Times Cited: 108
Helicobacter pylori infection and peptic ulcer disease in patients with advanced chronic liver disease
Tânia Carvalho, F. Costa, Sílvia Raquel Santos, et al.
Frontline Gastroenterology (2025), pp. flgastro-102944
Closed Access | Times Cited: 2
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2
Cell type-specific regulation of the pentose phoshate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidites, carcinogenesis, and aging
Katalin Bánki, András Perl
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103781-103781
Closed Access | Times Cited: 2
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF
Cornelius Engelmann, Abeba Habtesion, Mohsin Hassan, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1325-1338
Open Access | Times Cited: 64
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death
Alberto Zanetto, Elena Campello, Cristiana Bulato, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 660-669
Closed Access | Times Cited: 62
Loss of liver function in chronic liver disease: An identity crisis
Carmen Berasain, María Arechederra, Josepmaría Argemí, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 401-414
Open Access | Times Cited: 56
The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Cornelius Engelmann, Frank Tacke
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 652-652
Open Access | Times Cited: 40
Use of albumin infusion for cirrhosis-related complications: An international position statement
Zhaohui Bai, Nahúm Méndez‐Sánchez, Fernando Gomes Romeiro, et al.
JHEP Reports (2023) Vol. 5, Iss. 8, pp. 100785-100785
Open Access | Times Cited: 24
Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice
Yunhu Bai, Kenan Li, Xiaodong Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists
Michael Cooreman, Luisa Vonghia, Sven Francque
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111688-111688
Closed Access | Times Cited: 11
Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
Chao Chen, Ling Wei, Wenwen He, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102424-102424
Open Access | Times Cited: 9
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Correlation of Serum Zinc Levels with Hepatic Encephalopathy Severity in Patients with Decompensated Liver Cirrhosis: A Prospective Observational Study from Egypt
Atteyat A. Semeya, Rasha Elgamal, Amira A. A. Othman
Biological Trace Element Research (2025)
Open Access | Times Cited: 1
Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis
Warunee Mingpun, Agnieszka Sobanska, Mantiwee Nimworapan, et al.
Hepatology International (2025)
Closed Access | Times Cited: 1
The neurogliovascular unit in hepatic encephalopathy
Wouter Claeys, Lien Van Hoecke, Sander Lefere, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100352-100352
Open Access | Times Cited: 48
Management of refractory ascites
Florence Wong
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 16-32
Open Access | Times Cited: 30
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency
Thomas Winans, Zachary Oaks, G. Choudhary, et al.
Journal of Autoimmunity (2023) Vol. 140, pp. 103112-103112
Open Access | Times Cited: 22
Mechanisms of immunity in acutely decompensated cirrhosis and acute‐on‐chronic liver failure
Cornelius Engelmann, Ingrid W. Zhang, J. J. Clariá
Liver International (2023)
Open Access | Times Cited: 17
Correlation between sarcopenia and cirrhosis: a meta-analysis
Yifan Cui, Mingming Zhang, Jing Guo, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 8
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
Xuanyu Hao, Kai Zhang, Xingyong Huang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 636-643
Open Access | Times Cited: 8
Evolution of Liver Transplantation Indications: Expanding Horizons
Sara Battistella, Marco Grasso, Elisa Catanzaro, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 412-412
Open Access | Times Cited: 8
Splenectomy ameliorates liver cirrhosis by restoring the gut microbiota balance
Ye Jin, Meixin Shi, Jing Feng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 7
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure
Patrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Recompensation after TIPS reduces the incidence of hepatocellular carcinoma and increases survival in patients with cirrhosis
José Luis Alfonso Sánchez, Sheila González, Paloma Poyatos, et al.
Liver International (2024)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top